Systematic optimization of siRNA productive uptake into resting and activated T cells ex vivo by A. Kremer, T. Ryaykenen, RA Haraszti

Get full text

Pruritic papules and nodules as sign of persistent scabies infestation despite treatment according to current guidelines evidence for treatment resistance to ivermectin, benzylbenz... by P. Lehmann, A. Kremer, T. Assmann, R. Mang

Get full text

EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia by Jochen Rössler, Iris Baumgartner, Johanna A. Kremer Hovinga

Get full text

Growth Dependent Changes in Pressure Sensing Walkway Data for Turkeys by Jody A. Kremer, Cara I. Robison, Darrin M. Karcher

Get full text

Hypertension in patients with hereditary thrombotic thrombocytopenic purpura by Azra Borogovac, Erika Tarasco, Johanna A. Kremer Hovinga, James N. George

Get full text

Cerebral Venous Sinus Thrombosis Associated with Vaccine-Induced Thrombotic Thrombocytopenia—A Narrative Review by Adrian Scutelnic, Justine Brodard, Johanna A. Kremer Hovinga, Marcel Arnold, Mirjam R. Heldner

Get full text

Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes? by Stefanie Hausammann, Monique Vogel, Johanna A Kremer Hovinga, Sebastien Lacroix-Desmazes, Beda M Stadler, Michael P Horn

Get full text

Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors by Giancarlo Castaman, Flora Peyvandi, Johanna A. Kremer Hovinga, Roger E.G. Schutgens, Susan Robson, Katya Moreno, Víctor Jiménez-Yuste

Get full text

Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura by Dustin J. Little, Lauren M. Mathias, Evaren E. Page, Johanna A. Kremer Hovinga, Sara K. Vesely, James N. George

Get full text

GSK3ß, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9 by I. Dewachter, L. Ris, T. Jaworski, C.M. Seymour, A. Kremer, P. Borghgraef, H. De Vijver, E. Godaux, F. Van Leuven

Get full text

Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature by Vanessa Alexandra Buetler, Nada Agbariah, Deborah Pia Schild, Fabian D. Liechti, Anna Wieland, Nicola Andina, Felix Hammann, Johanna A. Kremer Hovinga

Get full text

Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature by Katarzyna A. Jalowiec, Martin Andres, Behrouz Mansouri Taleghani, Albulena Musa, Martina Dickenmann, Anne Angelillo-Scherrer, Alicia Rovó, Johanna A. Kremer Hovinga

Get full text

The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia by Dominik F. Draxler, Justine Brodard, Björn Zante, Stephan M. Jakob, Jan Wiegand, Johanna A. Kremer Hovinga, Anne Angelillo-Scherrer, Alicia Rovo

Get full text

S294: LONG-TERM SAFETY AND EFFICACY OF CAPLACIZUMAB FOR ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP): THE POST-HERCULES STUDY by M. Scully, J. de la Rubia, K. Pavenski, A. Metjian, P. Knöbl, F. Peyvandi, S. Cataland, P. Coppo, J. A. Kremer Hovinga, R. De Passos Sousa, F. Callewaert, S. Gunawardena, J. Lin

Get full text

Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case series by Andrea Ruberti, Johanna A. Kremer Hovinga, Federico Nappi, Aurora Vettese, Elena Bianchi, Eliana Fernandes, Elena Galfetti, Rita Monotti, Pamella Paul, Stefano Regazzoni, Daniela Valente, Davide Rossi, Georg Stussi, Bernhard Gerber

Get full text

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA by Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Filip Callewaert, Hilde De Winter

Get full text

Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocyt... by L. Kaynar, P. Coppo, M. Scully, J. De La Rubia, F. Peyvandi, S. Cataland, J. A. Kremer Hovinga, P. Knoebl, K. Pavenski, J. Minkue Mi Edou, F. Callewaert, R. De Passos Sousa

Get full text

LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY by Özgür Pektaş, Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Sriya Gunawardena, Julie Lin

Get full text

Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab by Pierre Fontana, Lorenzo Alberio, Manuela Albisetti, Anne Angelillo-Scherrer, Lars M. Asmis, Alessandro Casini, Bernhard Gerber, Lukas Graf, Inga Hegemann, Wolfgang Korte, Maria Martinez, Jan-Dirk Studt, Dimitrios A. Tsakiris, Walter A. Wuillemin, Johanna A. Kremer Hovinga

Get full text

A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyResearch in context by Henning Nilius, Adam Cuker, Sigve Haug, Christos Nakas, Jan-Dirk Studt, Dimitrios A. Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Schmidt, Walter A. Wuillemin, Bernhard Gerber, Johanna A. Kremer Hovinga, Prakash Vishnu, Lukas Graf, Alexander Kashev, Raphael Sznitman, Tamam Bakchoul, Michael Nagler

Get full text